Company profile: LifeLens Technologies
1.1 - Company Overview
Company description
- Provider of wearable personal health monitoring solutions, including the LifeLens Wireless ECG Monitor for adults with symptoms such as palpitations or dizziness; wearable physiological sensors for the U.S. Military to monitor health, readiness, and performance in real time; and an AI-enabled real-time physiological monitoring system for remote and in-hospital assessment of health readiness and performance.
Products and services
- Real-time Physiological Monitoring System: An AI-integrated platform that assesses health readiness and performance and enables remote and in-hospital patient monitoring across personal health applications
- Wearable Physiological Sensors: Real-time sensors designed for U.S. Military use that monitor health, readiness, and performance via wearable instrumentation
- LifeLens Wireless ECG Monitor: Wearable ECG instrumentation that monitors adult patients’ heart activity, capturing episodes associated with palpitations or dizziness during personal health monitoring
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LifeLens Technologies
Maya Medical
HQ: United States
Website
- Description: Provider of a novel percutaneous catheter for the treatment of hypertension in patients who are unable to effectively control blood pressure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Maya Medical company profile →
Micro Interventional Devices
HQ: United States
Website
- Description: Provider of percutaneous and minimally invasive structural heart repair technologies, including PolyCor polymeric anchors for soft-tissue cardiac applications; the MIA-T and MIA-M percutaneous annuloplasty systems for tricuspid and mitral valve regurgitation; and the Transcatheter Cardiac Repair platform enabling catheter-based treatment of structural heart disease without cardiopulmonary bypass.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micro Interventional Devices company profile →
Avenu Medical
HQ: United States
Website
- Description: Provider of the Ellipsys Vascular Access System, a minimally invasive solution for creating arteriovenous fistulas in hemodialysis patients, using thermal energy to fuse tissue without leaving foreign materials, pursuing unmet clinical needs with cost-effective, efficient approaches to vascular access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avenu Medical company profile →
Myocor
HQ: United States
Website
- Description: Provider of therapeutic cardiac technologies and evaluations to treat mitral regurgitation and heart failure, improving cardiac function. Offers the Coapsys System, a device and therapy for mitral valve insufficiency via a less invasive, off-pump, closed-heart procedure. Founded in 1996 and based in Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myocor company profile →
Corvidia Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage research, development, and commercialization of transformative therapies for cardio-renal diseases, currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corvidia Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LifeLens Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LifeLens Technologies
2.2 - Growth funds investing in similar companies to LifeLens Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LifeLens Technologies
4.2 - Public trading comparable groups for LifeLens Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →